RIBONE 35 Israel - English - Ministry of Health

ribone 35

unipharm ltd, israel - risedronic acid - tablets - risedronic acid 35 mg - risedronic acid - risedronic acid - treatment of postmenopausal osteoporosis to reduce the risk of vertebral fractures. treatment of established postmenopausal osteoporosis to reduce the risk of hip fractures. prevention of osteoporosis in postmenopausal women with increased risk of osteoporosis. treatment of osteoporosis in men at high risk of fracture.

LOTAN PLUS Israel - English - Ministry of Health

lotan plus

unipharm ltd, israel - hydrochlorothiazide; losartan potassium - tablets - losartan potassium 50 mg; hydrochlorothiazide 12.5 mg - lotan plus is indicated for the treatment of hypertension, for patients in whom combination therapy is appropriate. to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy.

PROLEUKIN Israel - English - Ministry of Health

proleukin

megapharm ltd - aldesleukin - powder for solution for infusion - aldesleukin 18 miu - aldesleukin - proleukin (aldesleukin) is indicated for the treatment of adults with metastatic renal cell carcinoma (metastatic rcc). proleukin is indicated for the treatment of adults with metastatic melanoma.careful patient selection is mandatory prior to the administration of proleukin.

VENLAFAXINE XR TEVA  75 MG Israel - English - Ministry of Health

venlafaxine xr teva 75 mg

teva pharmaceutical industries ltd, israel - venlafaxine as hydrochloride - capsules - venlafaxine as hydrochloride 75 mg - venlafaxine - venlafaxine - for the treatment of depression. maintenance of recurrent depression. generalized anxiety disorder (gad) - short term and long-term. social anxiety disorder (sad).

VENLAFAXINE XR TEVA  150 MG Israel - English - Ministry of Health

venlafaxine xr teva 150 mg

teva pharmaceutical industries ltd, israel - venlafaxine as hydrochloride - capsules - venlafaxine as hydrochloride 150 mg - venlafaxine - venlafaxine - for the treatment of depression. maintenance of recurrent depression. generalized anxiety disorder (gad) - short term and long-term. social anxiety disorder (sad).

EVOREL SEQUI Israel - English - Ministry of Health

evorel sequi

j-c health care ltd - estradiol as hemihydrate; estradiol as hemihydrate; norethisterone acetate - patches - estradiol as hemihydrate 3.2 mg; norethisterone acetate 11.2 mg; estradiol as hemihydrate 3.2 mg - estradiol, combinations - estradiol, combinations - hormone replacement therapy for the relief of menopausal symptoms.

ACAMOL TSINUN & SHAPA'AT NIGHT Israel - English - Ministry of Health

acamol tsinun & shapa'at night

teva israel ltd - chlorpheniramine maleate; dextromethorphan hydrobromide; paracetamol; pseudoephedrine hydrochloride - caplets - paracetamol 500 mg; chlorpheniramine maleate 2 mg; pseudoephedrine hydrochloride 30 mg; dextromethorphan hydrobromide 15 mg - paracetamol - for the relief of cold, cough and nasal congestion associated with fever and pain, for night care.

MYCOSTER 8 % NAIL LACQUER Israel - English - Ministry of Health

mycoster 8 % nail lacquer

perrigo israel agencies ltd - ciclopirox - lacque - ciclopirox 8 %w/w - ciclopirox - treatment of fungal infections of the nails.

LOTAN PLUS Israel - English - Ministry of Health

lotan plus

unipharm ltd, israel - hydrochlorothiazide; losartan potassium - tablets - losartan potassium 50 mg; hydrochlorothiazide 12.5 mg - lotan plus is indicated for the treatment of hypertension, for patients in whom combination therapy is appropriate. to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy.

RISPOND 1 Israel - English - Ministry of Health

rispond 1

unipharm ltd, israel - risperidone - coated tablets - risperidone 1 mg - risperidone - risperidone is indicated for the management of schizophrenia and manifestation of psychotic disorders. the antipsychotic efficacy of risperidone was established in short-term (6 to 8-weeks) controlled trials of schizophrenic inpatients. risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.risperidone is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe alzheimer’s dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment-requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years.risperidone is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated, expansive or irritable mood, inflated self-esteem, decreased need for sleep, pressured speech, racing thoughts, distractibility, or poor judgment, including disruptive or aggressive behaviors